Calcitriol Alleviates MPP(+)- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease

por Hu, Junjie, Wu, Jiawei, Wan, Fang, Kou, Liang, Yin, Sijia, Sun, Yadi, Li, Yunna, Zhou, Qiulu, Wang, Tao
Publicado 2021

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease

por Li, Yunna, Xia, Yun, Yin, Sijia, Wan, Fang, Hu, Junjie, Kou, Liang, Sun, Yadi, Wu, Jiawei, Zhou, Qiulu, Huang, Jinsha, Xiong, Nian, Wang, Tao
Publicado 2021

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson’s Disease?

por Yin, Sijia, Han, Chao, Xia, Yun, Wan, Fang, Hu, Junjie, Kou, Liang, Sun, Yadi, Wu, Jiawei, Li, Yunna, Zhou, Qiulu, Xiong, Nian, Huang, Jinsha, Wang, Tao
Publicado 2022

Efficacy and safety of 3‐n‐butylphthalide for the treatment of cognitive impairment: A systematic review and meta‐analysis

por Zhou, Qiulu, Han, Chao, Xia, Yun, Wan, Fang, Yin, Sijia, Li, Yunna, Kou, Liang, Chi, Xiaosa, Hu, Junjie, Sun, Yadi, Wu, Jiawei, Zou, Wenkai, Huang, Jinsha, Wang, Tao
Publicado 2022

The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome

por Kou, Liang, Chi, Xiaosa, Sun, Yadi, Han, Chao, Wan, Fang, Hu, Junjie, Yin, Sijia, Wu, Jiawei, Li, Yunna, Zhou, Qiulu, Zou, Wenkai, Xiong, Nian, Huang, Jinsha, Xia, Yun, Wang, Tao
Publicado 2022